A supply chain resilience model for business continuity: The way forward for highly regulated industries

The COVID-19 outbreak is a black swan event that has uncovered the delicateness of global supply chains and business architecture. Underpinned by the agency theory and institutional theory, a proposition for business continuity in the highly regulated pharma industry is presented in this paper. A cr...

Full description

Bibliographic Details
Main Authors: Aigbogun, Osaro, Xing, M., Fawehinmi, O., Ibeabuchi, C., Ehido, A., Ahmad, R.B., Abdullahi, M.S.
Format: Journal Article
Published: 2022
Online Access:http://hdl.handle.net/20.500.11937/89426
Description
Summary:The COVID-19 outbreak is a black swan event that has uncovered the delicateness of global supply chains and business architecture. Underpinned by the agency theory and institutional theory, a proposition for business continuity in the highly regulated pharma industry is presented in this paper. A cross-sectional quantitative study was carried out on a sample of 102 pharma supply chain executives in Malaysia. The primary data were gathered by administering a self-administered questionnaire and analyzed using the partial least squares structural equation modelling (PLS-SEM). The result reveals that supply chain orientation directly influences supply chain resilience. Also, introducing collaborative regulation as a mediator in this relationship shows partial mediation. The notion of collaborative regulation as a behavioral governance mechanism is relatively new, thus, presenting interesting opportunities for further exploration of the subject matter.